TITLE

Molecular Biomarkers for the Treatment of Lung Cancer: Personalized Therapy Beyond the EGFR Mutation

AUTHOR(S)
Suda, Kenichi; Mitsudomi, Tetsuya
PUB. DATE
May 2013
SOURCE
Current Medical Literature: Lung Cancer;2013, Vol. 6 Issue 4, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the use of molecular biomarkers to predict the benefits of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) to patients with lung cancer. The authors studied whether biomarkers are predictive or prognostic in lung cancer patients. They explained that oncogenic driver mutations are useful molecular biomarkers for lung cancer with targetable molecules. Information on EGFR mutation and clinical trials of molecular biomarkers is described.
ACCESSION #
88315321

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics